Platinum‐induced peripheral neurotoxicity: From pathogenesis to treatment
Nathan P. Staff(Mayo Clinic), Stefano Tamburin(University of Verona), Dimitri Psimaras(Université Claude Bernard Lyon 1), Guido Cavaletti(Bellvitge University Hospital), Maryam B. Lustberg(Yale Cancer Center), Badrul Islam(Erasmus University Rotterdam)
Cited by 149
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
|Neurology Neuroimmunology & Neuroinflammation|2021|702
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374